RC2NB’s mission is to strengthen internationally recognized expertise and innovative research projects and complement them with the development and validation of digital biomarkers and innovative methods of information processing and artificial intelligence.

Improving the life of people with MS and neuroimmunological diseases through the development of innovative tools that comprehensively characterize the disease process, facilitate the development and implementation of better treatments and enable personalized disease management.